B cell superantigens: Possible roles in immunodeficiency and autoimmunity

Seminars in Immunology

Volumn 10, Issue 1, 1998, Pages 43-55

  Silverman, Gregg J ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Autoimmunity; Protein Fv; Repertoire; Staphylococcal protein A; Superantigen

Indexed keywords

B LYMPHOCYTE ANTIGEN; IMMUNOGLOBULIN; IMMUNOGLOBULIN F(AB) FRAGMENT; LYMPHOCYTE ANTIGEN RECEPTOR; STAPHYLOCOCCUS PROTEIN A; SUPERANTIGEN;

ANTIGEN BINDING; AUTOIMMUNE DISEASE; B LYMPHOCYTE ACTIVATION; BINDING SITE; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; LYMPHOCYTE CLONE; PROTEIN PROTEIN INTERACTION; REVIEW; T LYMPHOCYTE;

EID: 0032006753     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1006/smim.1997.0104     Document Type: Article

References (116)

1. 1. White J, Herman A, Pullen AM, Kubo R, Kappler JW, Marrack P (1989) The V beta-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 56:27-35
2. 2. Marrack P, Winslow GM, Choi Y, Scherer M, Pullen A, White J, Kappler JW (1993) The bacterial and mouse mammary tumor virus superantigens; two different families of proteins with the same functions. Immunol Rev 131:79-92
3. 3. Pullen AM, Wade T, Marrack P, Kappler JW (1990) Identification of the region of T cell receptor beta chain that interacts with the self-superantigen Mis-la. Cell 61:1365-1374
4. 4. Foster TJ, McDevitt D (1994) Surface-associated proteins of Staphylococcus aureus: their possible roles in virulence. FEMS Microbiol Lett 118:199-205
5. 5. Patel AH, Nowlan P, Weavers ED, Foster T (1987) Virulence of protein A-deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement. Infect Immunol 55:3103-3110
6. 6. Sjodahl J (1977) Structural studies on the four repetitive Fc-binding regions in protein A from Staphylococcus aureus. Eur J Biochem 78:471-479
7. 7. Lofdahl S, Guss B, Uhlen M, Philipson L, Lindberg M (1983) Gene for staphylococcal protein A Proc Natl Acad Sci USA 80:697-701
8. 8. Uhlen M, Guss B, Nilsson B, Gatenbeck S, Philipson L, Lindberg M (1984) Complete sequence of the staphylococcal gene encoding protein A. A gene evolved through multiple duplications. J Biol Chem 259:1695-1702
9. 9. Moks T, Abrahmsen L, Nilsson B, Hellman U, Sjoquist J, Uhlen M (1986) Staphylococcal protein A consists of five IgG-binding domains. Eur J Biochem 156:637-643
10. 10. Deisenhofer J, Jones TA, Huber R, Sjodahl J, Sjoquist J (1978) Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9-and 2.8-resolution. Hoppe-Seylers Z Physiol Chem 359:975-985
11. 11. Gouda H, Torigoe H, Saito A, Sato M, Arata Y, Shimada I (1992) Three-dimensional solution structure of the B domain of staphylococcal protein A: comparisons of the solution and crystal structures. Biochemistry 31:9665-9672
12. 13C NMR study of the mode of interaction in solution of the B fragment of staphylococcal protein A and the Fc fragments of mouse immunoglobulin G. FEBS Lett 328:49-54
13. H 3-restricted unconventional bacterial antigen. J Immunol 151:5840-5855
14. 14. Inganas M, Johansson SG, Sjoquist J (1981) Further characterization of the alternative protein-A interaction of immunoglobulins: demonstration of an Fc-binding fragment of protein A expressing the alternative reactivity. Scand J Immunol 14:379-388
15. 2-and Fc-mediated interactions of mammalian immunoglobulins with S. aureus and group C and G streptococci. Acta Pathol Microbiol Immunol Scand [B] 94:377-385
16. H 3 antibodies bind domain D of staphylococcal protein A. J Immunol 154:6437-6446
17. 17. Silverman GJ (1992) Human antibody responses to bacterial antigens: studies of a model conventional antigen and a proposed model B cell superantigen. Int Rev Immunol 9:57-78
18. 18. Johansson SG, Inganas M (1978) Interaction of polyclonal human IgE with protein-A from Staphylococcus aureus. Immunol Rev 41:248-260
19. H III subgroup. J Immunol 147:1877-1883
20. HIII H chains. J Immunol 142:2778-2783
21. 21. Harboe M, Folling I (1974) Recognition of two distinct groups of human IgM and IgA based on different binding to staphylococci. J Immunol 3:471
22. 22. Sasano M, Burton DR, Silverman GJ (1993) Molecular selection of human antibodies with an unconventional bacterial B cell superantigen. J Immunol 151:5822-5839
23. 23. Seppala I, Kaartinen M, Ibrahim S, Makela O (1990) Mouse Ig coded by VH families S107 or J606 bind to protein A. J Immunol 145:2989-2993
24. 24. Young WW, Tamura Y, Wolock DM, Fox JW (1984) Staphylococcal protein A binding to the Fab of mouse monoclonal antibodies. J Immunol 133:3163-3166
25. 25. Kozlowski LM, Soulika AM, Silverman GJ, Lambris JD, Levinson AI (1996) Complement activation by a B cell superantigen. J Immunol 157:1200-1206
26. 26. Fearon DT, Carter RH (1995) The CD19/CR2/TAPA-1 complex of B lymphocytes: linking natural to acquired immunity. Annu Rev Immunol 13:127-149
27. 27. Silverman GJ (1996) B-cell superantigens and the somatic diversification of immune repertoires: molecular and cellular implications. In: Human B-cell Superantigens (Zouali M, ed) pp 67-88. Landes Co, Austin, TX
28. 28. Silverman GJ, Pires R, Bouvet JP (1996) An endogenous sialoprotein and a bacterial B cell superantigen compete in their VH family-specific binding interactions with human Igs. J Immunol 157:4496-4502
29. H families. Int Immunol 2:41-50
30. 30. Myhre EB (1990) Interaction of bacterial immunoglobulin receptors with sites in the Fab region. In: Bacterial Immunoglobulin-Binding Proteins, Volume I (Boyle MDP, ed) pp 243-256. Academic Press, San Diego, CA USA
31. 31. Potter KN, Li YC, Capra JD (1996) Staphylococcal protein A simultaneously interacts with framework 1, complementarity region 2, and framework 3 on human VH3 encoded immunoglobulins. J Immunol 157:2982-2988
32. 32. Padlan EA (1994) Anatomy of the antibody molecule. Mol Immunol 31:169-217
33. 33. Riechmann L, Davies J (1995) Backbone asignment, secondary structure and Protein A binding of an isolated human antibody VH domain. J Biomolec NMR 6:141-152
34. 34. Hakoda M, Kamatani N, Hayashimoto-Kurumada S, Silverman GJ, Yamanaka H, Terai C, Kashiwazaki S (1996) Differential binding avidities of human IgM for staphylococcal protein A derive from specific germline VH3 gene usage. J Immunol 157:2976-2981
35. 35. Silverman GJ (1997) B-cell superantigens. Immunol Today 18:379-386
36. 36. Cazenave PA, Marche PN, Jouvin-Marche E, Voegtle D, Bonhomme F, Bandeira A Coutinho A (1990) V beta 17 gene polymorphism in wild-derived mouse strains: two amino acid substitution s in the V beta 17 region greatly alter T cell receptor specificity. Cell 63:717-728
37. 37. Pullen AM, Bill J, Kubo RT, Marrack P, Kappler JW (1991) Analysis of the interaction site for the self superantigen Mls-1a on T cell receptor V beta. J Exp Med 173:1183-1192
38. 38. White J, Pullen A, Choi K, Marrack P, Kappler JW (1993) Antigen recognition properties of mutant V beta 3 + T cell receptors are consistent with an immunoglobulin-like structure for the receptor. J Exp Med 177:119-125
39. HIII variable regions. Eur J Immunol 23:2682-2686
40. 40. Silverman GJ (1994) Superantigens and the spectrum of unconventional B cell antigens. Immunologist 2:51-57
41. 41. Silverman GJ (1995) Unconventional B-cell antigens and human immune repertoires. Ann NY Acad Sci 764:566-585
42. 42. Pirofski L, Lui R, DeShaw M, Kressel AB, Zhong Z (1995) Analysis of human monoclonal antibodies elicited by vaccination with a Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide vaccine. Infect Immunol 63:3005-3014
43. 43. Romagnani S, Giudizi MG, del Prete G, Maggi E, Biagiotti R, Almerigogna F, Ricci M (1982) Demonstration on protein A of two distinct immunoglobulin-binding sites and their role in the mitogenic activity of Staphylococcal aureus Cowan I on human B cells. J Immunol 129:596-602
44. 44. Romagnani S, Giudizi MG, Biagiotti R, Almerigogna F, Maggi E, del Prete G, Ricci M (1981) Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A containing Staphylococcus aureus. J Immunol 127:1307-1313
45. 45. Romagnani S, Giudizi GM, Almerigogna F, Biagiotti R, Alessi A, Mingari C, Liang CM, Moretta L, Ricci M (1986) Analysis of the role of Interferon-gamma, interleukin 2 and a third factor distinct from Interferon-gamma and interleukin 2 in human B cell proliferation. Evidence that they act at different times after B cell activation. Eur J Immunol 16:623-629
46. 46. Callard RE, Smith SH, Shields JG, Levinsky RJ (1986) T cell help in human antigen-specific antibody responses can be replaced by interleukin 2. Eur J Immunol 16:1037-1042
47. 47. Persson U, Inganas M, Smith CI, Hammarstrom I, Johansson SG (1989) Recombinant protein A of non-staphylococcal origin is not mitogenic for human peripheral lymphocytes. Mitogenicity of natural protein A is caused by a contaminant. Scand J Immunol 29:151-158
48. 48. Schrezenmeier H, Fleischer B (1987) Mitogenic activity of staphylococcal protein A is due to contaminating staphylococcal enterotoxins. J Immunol Methods 105:133-137
49. 49. Li L, Krajewski S, Reed JC, Choi YS (1997) The apoptosis and proliferation of SAC-activated B cells by IL-10 are associated with changes in Bcl-2, Bcl-xL, and Mcl-1 expression. Cell Immunol 178:33-41
50. 50. Kristiansen SV, Pascual V, Lipsky PE (1994) Staphylococcal protein A induces biased production of Ig by VH3-expressing B lymphocytes. J Immunol 153:2974-2984
51. 51. Levinson AI, Yi Z, Wheatley L, Kozlowski L, Zorn S (1993) IgM rheumatoid factor produced in response to S. aureus Cowan I: role of protein A and preferential utilization of VH3 heavy chains. J Immunol 150:237A
52. 52. Levinson AI, Tar L, Carafa C, Haidar M (1986) Staphylococcus aureus Cowan I. Potent stimulus of immunoglobulin M rheumatoid factor production. J Clin Invest 78:612-617
53. 53. Hardy RR, Hayakawa K, Shimizu M, Yamasaki K, Kishimoto T (1987) Rheumatoid factor secretion from human Leu-1 + B cells. Science 236:81-83
54. 54. Levinson AI, Dalal NF, Haidar M, Tar L, Orlow M (1987) Prominent IgM rheumatoid factor production by human cord blood lymphocytes stimulated in vitro with Staphylococcus aureus Cowan I. J Immunol 139:2237-2241
55. 55. Kozlowski LM, Running SR, Zheng Y, Wheatley LM, Levinson AI (1995) Staphylococcus aureus Cowan I-induced human immunoglobin responses: preferential IgM rheumatoid factor production and VH3 mRNA expression by protein A-binding B cells. J Clin Immunol 15:145-151
56. 56. Newkirk MM, Rauch J, Mageed RA, Jefferis R, Posnett DN, Silverman GJ (1993) Restricted immunoglobulin variable region gene usage by hybridoma rheumatoid factors from patients with systemic lupus erythematosus and rheumatoid arthritis. Mol Immunol 30:255-263
57. 57. Thompson KM, Randen I, Borretzen M, Forre O, Natvig JB (1994) Variable region gene usage of human monoclonal rheumatoid factors derived from healthy donors following immunization. Eur J Immunol 24:1771-1778
58. 58. Ermel RW, Kenny TP, Chen PP, Robbins DL (1993) Molecular analysis of rheumatoid factors derived from rheumatoid synovium suggests an antigen-driven response in inflamed joints. Arthritis Rheum 36:380-388
59. H and D segments on chromosomes 15q11.2 and 16p11.2. Hum Mol Genet 3:853-860
60. + B cells, the major B cell subset in the peripheral blood, express V kappa genes with no or little somatic mutation throughout life. Eur J Immunol 23:3272-3277
61. 61. Pascual V, Liu YJ, Magalski A, de Bouteiller O, Banchereau J, Capra JD (1994) Analysis of somatic mutation in five B cell subsets of human tonsil. J Exp Med 180:329-339
62. + B cells. J Clin Invest 99:2488-2501
63. 63. Berberian L, Shukla J, Jefferis R, Braun J (1994) Effects of HIV infection on VH3 (D12 idiotope) B cells in vivo. J Acquired Immune Deficiency Syndr 7:641-646
64. 64. Berberian L, Goodglick L, Kipps TJ, Braun J (1993) Immunoglobulin VH3 gene products: natural ligands for HIV gp120. Science 261:1588-1591
65. 65. Berberian L, Valles-Ayoub Y, Sun N, Martinez-Maza O, Braun J (1991) A VH clonal deficit in human immunodeficiency virus-positive individuals reflects a B-cell maturational arrest. Blood 78:175-179
66. 66. Muller S, Wang H, Silverman GJ, Bramlet G, Haigwood N, Kohler H (1993) B-cell abnormalities in AIDS: stable and clonally-estricted antibody response in HIV-I infection. Scand J Immunol 38:327-334
67. 67. David D, Demaison C, Bani L, Zouali M, Theze M (1995) Selective variations in vivo of VH3 and VH1 gene expression in peripheral B cell IgM, IgD and IgG during HIV infection. Eur J Immunol 25:1524-1528
68. 68. Goodglick L, Zevit N, Neshat MS, Braun J (1995) Mapping the Ig superantigen-binding site of HIV-1 gp120. J Immunol 155:5151-5159
69. 69. Karray S, Zouali M (1997) Identification of the B cell super-antigen-binding site of HIV-1 gp120. Proc Natl Acad Sci USA 94:1356-1360
70. 70. Bouvet JP, Pirès R, Lunel-Fabiani F, Crescenzo-Chaigne B, Maillard P, Valla D, Opolon P, Pillot J (1990) Protein F. A novel F(ab)-binding factor, present in normal liver, and largely released in the digestive tract during hepatitis. J Immunol 145:1176-1180
71. 71. Bouvet JP, Pirès R, Iscaki S, Pillot J (1993) Nonimmune macromolecular complexes of Ig in human gut lumen. Probable enhancement of antibody functions. J Immunol 151:2562-2571
72. 72. Bouvet JP, Pirès R, Charlemagne J, Pillot J, Iscaki S (1991) Non-immune binding of human protein Fv to immunoglobulins from various mammalian and non-mammalian species. Scand J Immunol 34:491-496
73. 73. Ruffet E, Pirès R, Pillot J, Bouvet JP (1994) Activation of the classical pathway of complement by non-immune complexes of immunoglobulin s with human protein FV (FV fragment-binding protein). Scand J Immunol 40:359-362
74. 74. Silverman GJ, Roben P, Bouvet J-P, Sasano M (1995) Super-antigen properties of a human sialoprotein involved in gutassociated immunity. J Clin Invest 96:417-426
75. 75. Herman JE, Alt FW (1990) Human heavy chain variable region gene diversity, organization, and expression. Int Rev Immunol 5:203-214
76. 76. Barbas SM, Ditzel HJ, Salonen EM, Yang WP, Silverman GJ, Burton DR (1995) Human autoantibodyrecognition of DNA Proc Natl Acad Sci USA 92:2529-2533
77. 77. Roben P, Barbas SM, Sandoval L, Lecerf JM, Stollar BD, Solomon A, Silverman GJ (1996) Repertoire cloning of lupus anti-DNA autoantibodies. J Clin Invest 98:2827-2837
78. 78. Mourad W, Mehindate K, Schall TJ, McColl SR (1992) Engagement of major histocompatibility complex class II molecules by superantigen induces inflammatory cytokine gene expression in human rheumatoid fibroblast-like synoviocytes. J Exp Med 175:613-616
79. 79. Friedman SM, Tumang JR, Crow MK (1993) Microbial superantigens as etiopathogenic agents in autoimmunity. Rheum Dis Clin North Am 19:207-222
80. 80. Tumang JR, Posnett DN, Cole BC, Crow MK, Friedman SM (1990) Helper T cell-dependent human B cell differentiation mediated by a mycoplasmal superantigen bridge. J Exp Med 171:2153-2158
81. 81. Tumang JR, Zhou JL, Gietl D, Crow MK, Elkon KB, Fried-man SM (1996) T helper cell-dependent, microbial superantigen-mediated B cell activation in vivo. Autoimmunity 2:247-255
82. 82. Schattner EJ, Elkon KB, Yoo DH, Tumang J, Krammer PH, Crow MK, Friedman SM (1995) CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway. J Exp Med 182:1557-1565
83. 83. He X, Goronzy JJ, Zhong W, Xie C, Weyand CM (1995) VH3-21 B cells escape from a state of tolerance in rheumatoid arthritis and secrete rheumatoid factor. Molec Med 1:768-780
84. 84. Hufnagle WO, Huang S-C, Suzuki I, Milner ECB (1995) A complete preimmune human VH3 repertoire. Ann NY Acad Sci 764:293-295
85. 85. Xie C, Bruhl H, He X, Weyand CM, Goronzy JJ (1995) Selective activation of VH3A10 + rheumatoid factor producing B cells by staphylococcal enterotoxin D. Int Immunol 7:425-434
86. 86. He XW, Goronzy J (1992) Selective induction of rheumatoid factors by superantigens and human helper T cells. J Clin Invest 89:673-680
87. 87. He X, Zhong W, McCarthy TG, Weyand CM, Goronzy JJ (1996) Increased responsiveness of rheumatoid factor-producing B cells in seronegative and seropositive rheumatoid arthritis. Arthritis Rheum 39:1499-1506
88. 88. Domiati-Saad R, Attrep JF, Brezinschek HP, Cherrie AH, Karp DR, Lipsky PE (1996) Staphylococcal enterotoxin D functions as a human B cell superantigen by rescuing VH4-expressing B cells from apoptosis. J Immunol 156:3608-3620
89. 89. Dintzis HM, Dintzis RZ, Vogelstein B (1976) Molecular determinants of immunogenicity: the immunon model of immune response. Proc Natl Acad Sci USA 73:3671-3675
90. 90. Bachmann MF, Rohrer UH, Kundig TM, Burki K, Hengartner H, Zinkernagel RM (1993) The influence of antigen organization on B cell responsiveness. Science 262:1448-1451
91. 91. Mond JJ, Lees A, Snapper CM (1995) T cell-independent antigens type 2. Annu Rev Immunol 13:655-692
92. 92. Bretscher P, Cohn M (1970) A theory of self-nonself discrimination: paralysis and induction involve the recognition of one or two determinants on antigen, respectively. Science 163:1042-1049
93. 93. Snapper CM, Mond JJ (1996) A model for induction of T cell-independent humoral immunity in response to polysaccharide antigens. J Immunol 157:2229-2233
94. 94. Daniels BF, Nakamura MC, Rosen SD, Yokoyama WM, Seaman WE (1994) Ly-49A, a receptor for H-2Dd, has a functional carbohydrate recognition domain. Immunity 1:785-792
95. 95. Gu H, Tarlington D, Muller W, Rajewsky K, Forster L (1991) Most peripheral B cells in mice are ligand selected. J Exp Med 173:1357-1371
96. 96. Pospisil R, Young-Cooper GO, Mage RG (1995) Preferential expansion and survival of B lymphocytes based on VH framework 1 and framework 3 expression: 'positive' selection in appendix of normal and VH-mutant rabbits. Proc Natl Acad Sci USA 92:6961-6965
97. 97. Dorner T, Brezinschek HP, Brezinschek RI, Foster SJ, Domiati-Saad R, Lipsky PE (1997) Analysis of the frequency and pattern of somatic mutations within nonproductively rearranged human variable heavy chain genes. J Immunol 158:2779-2789
98. 98. Hayakawa K, Hardy RR, Herzenberg LA (1986) Peritoneal Ly-1 B cells: genetic control, autoantibody production, increased lambda light chain expression. Eur J Immunol 16:450-456
99. 99. Kroese FG, Butcher EC, Stall AM, Lalor PA, Adams S, Herzenberg LA (1989) Many of the IgA producing plasma cells in murine gut are derived from self-replenishing precursors in the peritoneal cavity. Int Immunol 1:75-84
100. 100. Kantor AB, Merrill CE, Herzenberg LA Hillson JL (1997) An unbiased analysis of VH-D-JH sequences from B-1a, B-1b, and conventional B cells. J Immunol 158:1175-1186
101. 101. Cong YZ, Rabin E, Wortis HH (1991) Treatment of murine CD5-B cells with anti-Ig, but not LPS, induces surface CD5: two B-cell activation pathways. Int Immunol 3:467-476
102. 102. Words HH, Teutsch M, higer M, Zheng J, Parker DC (1995) B-cell activation by cross-linking of surface IgM or ligation of CD40 involves alternative signal pathways and results in different B-cell phenotypes. Proc Natl Acad Sci USA 92:3348-3352
103. 103. O'Garra A, Chang R, Go N, Hastings RAUG, Howard M (1992) Ly-1 B (B-1) cells are the main source of B cell-derived interleukin 10. Eur J Immunol 22:711-717
104. 104. Karras JG, Wang Z, Huo L, Howard RG, Frank DA, Rothstein TL (1997) Signal transducer and activator of transcription-3 (STAT3) is constitulively activated in normal, self-renewing B-1 cells but only inducibly expressed in conventional B lymphocytes [see comments]. J Exp Med 185:1035-1042
105. 105. Murakami M, Honjo T (1995) Involvement of B-1 cells in mucosal immunity and autoimmunity. Immunol Today 16:534-539
106. 106. Whitmore AC, Haughton G, Arnold LW (1996) Phenotype of B cells responding to the thymus-independent type-2 antigen polyvinyl pyrrolidinone. Int Immunol 8:533-542
107. 107. Huang CA, Henry C, Iacomini J, Imanishi-Kari T, Wortis HH (1996) Adult bone marrow contains precursors for CD5 + B cells. Eur J Immunol 26:2537-2540
108. 108. Schettino EW, Chai SK, Kasaian MT, Schroeder HWJ, Casali P (1997) VHDJH gene sequences and antigen reactivity of monoclonal antibodies produced by human B-1 cells: evidence for somatic selection. J Immunol 158:2477-2489
109. 109. Dono M, Zupo S, Augliera A, Burgio VL, Massara R, Melagrana A, Costa M, Grossi CE, Chiorazzi N, Ferrarini M (1996) Subepithelial B cells in the human palatine tonsil. II. Functional characterization. Eur J Immunol 26:2043-2049
110. 110. Jorgensen C, Couret I, Canovas F, Bologna C, Brochier J, Reme T, Sany J (1996) In vivo migration of tonsil lymphocytes in rheumatoid synovial tissue engrafted in SCID mice: involvement of LFA-1. Autoimmunity 24:179-185
111. 111. Brandtzaeg P, Halstensen TS, Kett K, Krajci P, Kvale D, Rognum TO, Scott H, Sollid LM (1989) Immunobiology and immunopathology of human gut mucosa: humoral immunity. Gastroenterology 97:1562-1584
112. 112. Casali P, Schettino EW (1996) Structure and function of natural antibodies. Curr Top Microbiol Immunol 210:167-179
113. 113. Melief MJ, Hoijer MA, Van Paassen HC, Hazenberg MP (1995) Presence of bacterial flora-derived antigen in synovial tissue macrophages and dendritic cells. Br J Rheumatol 34:1112-1116
114. 114. Barbas CF (1995) Synthetic human antibodies. Nat Med 1:837-839
115. 115. Hillson JL, Karr NS, Oppliger IR, Mannik M, Sasso EH (1993) The structural basis of germline-encoded VH3 immunoglobulin binding to staphylococcal protein A. J Exp Med 178:331-336
116. 116. Hakoda M, Hayashimoto S, Yamanaka H, Terai C, Kamatani N, Kashiwazaki S (1994) Molecular basis for the interaction between human IgM and staphylococcal protein A. Clin Immunol Immunopathol 72:394-401